Candel Therapeutics Inc (CADL)

May 05, 2026

Candel Therapeutics CEO urges stronger patient role to drive innovation at BioEquityEurope - Traders Union

May 05, 2026

May 04, 2026

Candel to discuss phase 3 prostate cancer trial data on May 15 - Investing.com UK

May 04, 2026

May 04, 2026

Candel to discuss phase 3 prostate cancer trial data on May 15 By Investing.com - Investing.com Australia

May 04, 2026

May 04, 2026

Candel Therapeutics to review Phase 3 prostate cancer data in May 15 call - Proactive financial news

May 04, 2026

May 04, 2026

Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting - The Manila Times

May 04, 2026

May 04, 2026

Candel lines up May 15 call after prostate cancer trial data at AUA - Stock Titan

May 04, 2026

May 01, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 01, 2026

May 01, 2026

Two new Candel hires get options to buy 29,400 shares at $6.18 - Stock Titan

May 01, 2026

Apr 29, 2026

Candel Therapeutics (NASDAQ: CADL) details 2026 virtual vote on directors and KPMG - Stock Titan

Apr 29, 2026

Apr 29, 2026

[ARS] Candel Therapeutics, Inc. SEC Filing - Stock Titan

Apr 29, 2026

Apr 29, 2026

Small cap wrap: C3 Metals, Candel Therapeutics, BioHarvest Sciences… - Proactive financial news

Apr 29, 2026

Apr 29, 2026

Candel Therapeutics teams up with EVERSANA to prep for prostate cancer drug launch - Yahoo Finance

Apr 29, 2026

Apr 29, 2026

Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer - The Manila Times

Apr 29, 2026

Apr 29, 2026

Candel picks EVERSANA over building its own sales force for prostate launch - Stock Titan

Apr 29, 2026

Apr 27, 2026

BlackRock files Schedule 13G/A reporting 3,079,861 CADL shares (NYSE: CADL) - Stock Titan

Apr 27, 2026

Apr 27, 2026

How (CADL) Movements Inform Risk Allocation Models - Stock Traders Daily

Apr 27, 2026

Apr 27, 2026

CADL Forecast, Price Target & Analyst Ratings | CANDEL THERAPEUTICS INC (NASDAQ:CADL) - ChartMill

Apr 27, 2026

Apr 26, 2026

Candel Therapeutics Stock Soars On FDA’s RMAT Designation For Prostate Cancer Therapy: Retail Considers It Good Long-Term Buy - MSN

Apr 26, 2026

Apr 23, 2026

CADL (Candel Therapeutics Inc.) reports wide Q4 2025 EPS miss while notching slight share gains on stable investor sentiment.Hot Momentum Watchlist - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026

Apr 23, 2026

Candel Therapeutics Stock Jumps On Upbeat Q1 Earnings: Retail Gets More Bullish - MSN

Apr 23, 2026

Apr 22, 2026

Mapping Candel Therapeutics' Sprint To The BLA Finish Line - Bioprocess Online

Apr 22, 2026

Apr 21, 2026

Candel Therapeutics: 'Cancer Vaccine' Buy Thesis Appears Compelling (NASDAQ:CADL) - Seeking Alpha

Apr 21, 2026

Apr 20, 2026

CADL Initiated Coverage By Cantor Fitzgerald -- Rating Overweigh - GuruFocus

Apr 20, 2026

Apr 20, 2026

Candel Therapeutics Stock Soars After Cantor Fitzgerald's Overweight Rating - Benzinga

Apr 20, 2026

Apr 20, 2026

Insiders Rewarded With US$506k Addition To Investment As Candel Therapeutics Stock Hits US$467m - 富途牛牛

Apr 20, 2026

Apr 20, 2026

Is Candel (CADL) stock forming a continuation pattern (Leaps) 2026-04-20High Interest Stocks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026

Apr 20, 2026

CADL Stock Posted Its Best Day In Nearly 16 Months On Friday – Why Does Cantor See A Further 370% Upside? - Stocktwits

Apr 20, 2026

Apr 18, 2026

10 Health Care Stocks Moving In Friday's Intraday Session - Sahm

Apr 18, 2026

Apr 16, 2026

Targeted oncology therapies expand industry interest for Candel Therapeutics - Traders Union

Apr 16, 2026

Apr 16, 2026

Trading Systems Reacting to (CADL) Volatility - Stock Traders Daily

Apr 16, 2026

Apr 16, 2026

Candel Therapeutics, Inc. (CADL) Stock Analysis: Exploring a 266.50% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Apr 16, 2026

Apr 14, 2026

Candel Therapeutics advances viral immunotherapies in prostate lung and brain cancer programs - Traders Union

Apr 14, 2026

Apr 13, 2026

Aug Analyst Calls: Should I hold or sell Candel Therapeutics Inc now2026 Recap & AI Enhanced Execution Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN

Apr 12, 2026

Apr 12, 2026

Candel Therapeutics, Inc. (NASDAQ:CADL) Given Average Rating of "Hold" by Brokerages - MarketBeat

Apr 12, 2026

Apr 09, 2026

Candel Therapeutics (NASDAQ:CADL) Downgraded by Zacks Research to Strong Sell - MarketBeat

Apr 09, 2026

Apr 08, 2026

Candel Therapeutics, Inc. prepares new immunotherapy data release at AUA2026 - Traders Union

Apr 08, 2026

Apr 07, 2026

Dow Update: Is Candel Therapeutics Inc affected by consumer sentimentMarket Risk Report & Momentum Based Trading Ideas - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Winners Losers: Can Candel Therapeutics Inc be the next market leaderWeekly Profit Recap & Capital Efficient Trade Techniques - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Should I Buy Candel (CADL) Stock Now | Price at $5.15, Up 3.00%Hedge Fund Favorites - Cổng thông tin điện tử Tỉnh Sơn La

Apr 06, 2026

Apr 03, 2026

Candel Therapeutics, Inc. (CADL) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 03, 2026

Apr 03, 2026

CADL Stock Analysis: Candel Therapeutics Inc. Biotech at 5 Dollar Level Post Mild Daily Uptick - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 03, 2026

Apr 02, 2026

Candel Therapeutics, Inc. (CADL) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026

Apr 02, 2026

Candel Therapeutics Inc. (CADL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Apr 02, 2026

Apr 02, 2026

Candel Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Apr 02, 2026

Apr 02, 2026

Candel Therapeutics (CADL) director granted 4,618 fully vested stock options - Stock Titan

Apr 02, 2026

Apr 02, 2026

Director at Candel Therapeutics (NASDAQ: CADL) gets 2,795 options - Stock Titan

Apr 02, 2026

Apr 02, 2026

Candel Therapeutics (CADL) director granted fully vested stock options in lieu of cash fees - Stock Titan

Apr 02, 2026